Oct
2026
Fiera Milano, Italy
Visit us
stand 3F18, API
Zone

Linnea SA

Exhibitor at CPHI Milan 2026
About Us

Linnea is a Swiss-based company specializing in the extraction of premium botanical ingredients for the pharmaceutical, nutraceutical, and cosmetic industries.
Utilizing advanced extraction technologies, the company produces sustainable, GMP-certified botanicals for applications ranging from OTC drugs to health supplements. With its portfolio of high-quality ingredients, Linnea also stands out as a leader in the emerging medical cannabinoids sector, where it applies a pharma-driven approach to the development of cannabinoid-based therapies in line with strict pharmaceutical standards

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Switzerland
  • Founded:
    1982
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    50 - 99
Company types
Manufacturer/Innovator
Primary activities
API Producer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 3F18, API

Products Featured at CPHI Milan 2026

  • HMRlignan

    Product HMRlignan

    Lignans are plant compounds with well-established bioactive properties, known to support vitality and resilience in plants. Linnea's HMRlignan is a rich source of lignans, providing a significantly higher concentration compared to typical dietary sources. Highly purified Norway Spruce lignans. 7-HMR co-cry...
  • Red Clover

    Product Red Clover

    Linnea’s Red Clover botanical extract is extracted using a unique formula, balancing the main four Red Clover isoflavones,consistent through every batch. Linnea thus ensures consistent quality and standardization of Red Clover. 
  • Vincamine

    Product Vincamine

    Vincamine is a semi-synthetic derivative, extracted using a proprietary methodto Linnea, vetted to GMP-standard quality controls, obtaining a state-of-theartproduct. Vincamine is CEP certified, and complies with Ph.Eur. monograph“Vincamine”, that Linnea developed.
  • Vinpocetine

    Product Vinpocetine

    Linnea’s Vinpocetine is a semi-synthetic derivative, extracted using a provenmethod, vetted with in-house GMP-standard quality controls, resulting in ahigh-quality profile and outstanding therapeutic value end product. Linnea’sVinpocetine is compliant with the European Pharmacopoeia and is CEP certified.
  • Butylscopolamine

    Product Butylscopolamine

    Linnea’s Vinpocetine is a semi-synthetic derivative, extracted using a provenmethod, vetted with in-house GMP-standard quality controls, resulting in ahigh-quality profile and outstanding therapeutic value end product. Linnea’sVinpocetine is compliant with the European Pharmacopoeia and is CEP certified.

Linnea SA Resources (1)

  • Biogas: Linnea as a suistainable company

    Video Biogas: Linnea as a suistainable company

    Sustainability is a company-wide priority:we partner with local farmers in the Swiss canton of Ticino converting organic waste into energy thanks to a biogas plant, and we voluntarily adhere to the Swiss Private Sector Energy Agency Program, for a minimal CO2 footprint.
    2024-09-16